Related references
Note: Only part of the references are listed.Wnt signaling and cellular metabolism in osteoblasts
Courtney M. Karner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Parathyroid Hormone-Related Protein Protects Osteoblastic Cells From Oxidative Stress by Activation of MKP1 Phosphatase
Juan A. Ardura et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Parathyroid hormone 1-34 and skeletal anabolic action THE USE OF PARATHYROID HORMONE IN BONE FORMATION
L. Osagie-Clouard et al.
BONE & JOINT RESEARCH (2017)
Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study
Lucia Forte et al.
ACTA BIOMATERIALIA (2017)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Bente Langdahl et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2016)
Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta Analysis
Zhongju Shi et al.
PLOS ONE (2016)
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis
Francisco Javier Manzano-Moreno et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2015)
The WNT system: background and its role in bone
U. H. Lerner et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies
Pierre J. Marie
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues
Wei Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature
P. Chatakun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Extracellular modulators of Wnt signalling
Tomas Malinauskas et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)
Osteoblastic protein tyrosine phosphatases inhibition and connexin 43 phosphorylation by alendronate
V. Lezcano et al.
EXPERIMENTAL CELL RESEARCH (2014)
Markers of inflammation after zoledronic acid redosing
Antonis Sykiotis et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss
R. A. Lindtner et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Role of Osteopontin in Modulation of Hydroxyapatite Formation
Graeme K. Hunter
CALCIFIED TISSUE INTERNATIONAL (2013)
Zoledronic Acid Inhibits Human Osteoblast Activities
Fernanda G. Basso et al.
GERONTOLOGY (2013)
Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model
Koichiro Komatsu et al.
JOURNAL OF ENDOCRINOLOGY (2013)
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects
Addolorata Corrado et al.
JOURNAL OF RHEUMATOLOGY (2013)
Bisphosphonates: Focus on Inflammation and Bone Loss
Tommaso Iannitti et al.
AMERICAN JOURNAL OF THERAPEUTICS (2012)
Effects of alendronate on human osteoblast-like MG63 cells and matrix metalloproteinases
Jun Sun et al.
ARCHIVES OF ORAL BIOLOGY (2012)
Bisphosphonates: effects on osteoblast
Nicola Maruotti et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Update on Wnt signaling in bone cell biology and bone disease
David G. Monroe et al.
GENE (2012)
Loss of Wnt/β-Catenin Signaling Causes Cell Fate Shift of Preosteoblasts From Osteoblasts to Adipocytes
Lige Song et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Teresita Bellido et al.
BONE (2011)
Lrp5 functions in bone to regulate bone mass
Yajun Cui et al.
NATURE MEDICINE (2011)
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
Jun Guo et al.
CELL METABOLISM (2010)
Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in Vivo
Helmut Glantschnig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats
Beverley Fermor et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Alendronate Enhances Osteogenic Differentiation of Bone Marrow Stromal Cells: A Preliminary Study
Hyung Keun Kim et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Inhibition of Osteoblast Function In Vitro by Aminobisphosphonates
Isabel R. Orriss et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Effects of Alendronate on the Proliferation and Osteogenic Differentiation of MG-63 Cells
Y. Xiong et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro
Aymen I. Idris et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Wnt signaling and skeletal development
Fei Liu et al.
CELLULAR SIGNALLING (2008)
Parathyroid hormone signaling through low-density lipoprotein-related protein 6
Mei Wan et al.
GENES & DEVELOPMENT (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
PTH/cAMP/PKA Signaling Facilitates Canonical Wnt Signaling Via Inactivation of Glycogen Synthase Kinase-3β in Osteoblastic Saos-2 Cells
Akira Suzuki et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Minireview:: The genetics of low-density lipoprotein Receptor-related protein 5 in bone:: A story of extremes
Wendy Balemans et al.
ENDOCRINOLOGY (2007)
Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
Robert Lindsay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro
S. Greiner et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2007)
Extra-skeletal effects of bisphosphonates
Addolorata Corrado et al.
JOINT BONE SPINE (2007)
Current perspectives on NMDA-type glutamate signalling in bone
Gary J. Spencer et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Function and biological roles of the Dickkopf family of Wnt modulators
C. Niehrs
ONCOGENE (2006)
Cyclin D1-Cdk4 induce Runx2 ubiquitination and degradation
Run Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass
Frederic Morvan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Parathyroid hormone increases β-catenin levels through Smad3 in mouse osteoblastic cells
T Tobimatsu et al.
ENDOCRINOLOGY (2006)
Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice
MM Hurley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells
F von Knoch et al.
BIOMATERIALS (2005)
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression
T Gaur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects
A Corrado et al.
CLINICAL RHEUMATOLOGY (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes
TP Hill et al.
DEVELOPMENTAL CELL (2005)
Regulation of osteoblastogenesis and bone mass by Wnt10b
CN Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Osteoblast proliferation and maturation by bisphosphonates
GI Im et al.
BIOMATERIALS (2004)
Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation
FP Cantatore et al.
CLINICAL RHEUMATOLOGY (2004)
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)
BQ Pan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts - A putative explanation for why intermittent administration is needed for bone anabolism
T Bellido et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures
F Itoh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
High bone mass in mice expressing a mutant LRP5 gene
P Babij et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Parathyroid hormone bone anabolic action requires Bbfa1/Runx2-dependent signaling
V Krishnan et al.
MOLECULAR ENDOCRINOLOGY (2003)
Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone
DD Bikle et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Bisphosphonates influence the proliferation and the maturation of normal human osteloblasts
O Fromigué et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2002)
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
M Kato et al.
JOURNAL OF CELL BIOLOGY (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation
K Nakashima et al.
CELL (2002)
Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts
V Viereck et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro
I Mathov et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent
JT Swarthout et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells
Y Abe et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2000)
In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment
D Stanislaus et al.
BONE (2000)
Share Paper
